Loading...

Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada

Saved in:
Bibliographic Details
Main Authors: Gerth, William C, Betschel, Stephen D, Zbrozek, Arthur S
Format: Artigo
Language:Inglês
Published: BioMed Central 2014
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4125998/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1710-1492-10-S1-A42
Tags: Add Tag
No Tags, Be the first to tag this record!